A vaccine against geopolitical rivalries
Victor Angelo
Boris
Johnson convened an extraordinary virtual G7 summit today. He justified it by
saying it was urgent to find an agreement that would allow a global response to
covid-19, i.e. access for all to the immunisation possible. He added that it
would also be an opportunity to coordinate demand for vaccines to avoid a
headlong rush to the few quantities already available. The summit would be the
occasion to resolve the competition between states, which, if it continues,
could lead to serious political fractures between traditional partners, as seen
recently in the increased tension between the EU and the London government.
The
UK holds the G7 presidency in 2021. Hence the legitimacy of Johnson's
initiative. But the prime minister may have other objectives well beyond
seeking a global response to the pandemic. The man is a skilled politician with
a knack for spectacular actions. He will try to make the most of the
opportunity that the leadership of the G7 offers him to show his constituents
that he has a global stature capable of setting the agenda of the group of the
most developed countries. If this translates into an increase in international
cooperation, which badly needs to be stimulated, we can only be grateful.
I
fear, however, that it will not achieve that result. The subject of the meeting
is clearly a priority, but it cannot be limited to the G7 countries. It is true
that Australia, South Korea, and India have also been invited to take part in
the summit. India counts in terms of vaccine production. But the invitation
reflects, above all, the UK's specific interest in strengthening its relations
with these countries and not the contribution they can make to getting vaccines
to the poorest and most remote parts of the world. It also reflects another political
agenda, one that is shared by others, especially Joe Biden. That of thwarting
the geopolitical ambitions of the main rivals of the United States and its
Western allies. But making international policy at the cost of a pandemic does
not seem to me to be ethically acceptable.
In
fact, it would be more appropriate to organise a G20 meeting to deal with the
harmonisation of vaccine distribution and define everyone's contribution to
achieving this objective. The G20 has the merit of sitting at the same table
all the G7 countries plus China and Russia, among others. Coordination with
these two States is fundamental for a rapid, effective, and generalised fight
against the virus. The intrusion of hegemonic rivalries should not be admitted
when it comes to responding to a problem that threatens the health of all,
social progress, and the stability of the future. According to World Bank
estimates, the pandemic has already pushed a dramatic number of people back
into extreme poverty - it could be around 115 million. Moreover, the lack of
access to vaccines for people in the poorest countries will cause a global
distortion with unimaginable consequences. Among other things, international
inequalities would become even more accentuated, even explosive. The worsening of
imbalances between regions of the globe is one of the greatest risks facing us.
The
G20 is currently chaired by Italy. The Italian executive, now with Mario Draghi
at its head, faces immense internal problems. It is not in a position to play a
leading role on the international stage at a time when the latter needs a giant
to mobilise it in an undisputed way. Draghi is scheduled to hold a global
summit in Rome on 21 May on the pandemic and related issues. May is, however,
an eternity away when urgent decisions are needed.
In
the meantime, in a positive spirit, I hope that today's G7 meeting will make it
possible to strengthen COVAX, the mechanism set up by the WHO, in collaboration
with various organisations, to guarantee countries with limited financial and
operational resources equitable access to covid vaccines. If this happens, we
will have to recognise that the initiative taken by Boris Johnson will have had
some merit.
(Automatic translation of the opinion piece I published today in the
Diário de Notícias, the old and prestigious Lisbon newspaper)
No comments:
Post a Comment